CAS: 1233332-37-0 - 1-[[[5′-[[1-(4-Chloro-3-methylphenyl)ethyl]amino]-2′-fluoro-3,5-dimethyl[1,1′-biphenyl]-4-yl]carbonyl]amino]cyclopropanecarboxylic acid

Fórmula: C₂₈H₂₈ClFN₂O₃

InChI: InChI=1S/C28H28ClFN2O3/c1-15-11-19(5-7-23(15)29)18(4)31-21-6-8-24(30)22(14-21)20-12-16(2)25(17(3)13-20)26(33)32-28(9-10-28)27(34)35/h5-8,11-14,18,31H,9-10H2,1-4H3,(H,32,33)(H,34,35)

Chave InChI: InChIKey=YVHNBORUVLWCKF-UHFFFAOYSA-N

SMILES: O=C(O)C1(NC(=O)C2=C(C=C(C=C2C)C=3C=C(C=CC3F)NC(C4=CC=C(Cl)C(=C4)C)C)C)CC1

1-[[[5'-[[1-(4-Chloro-3-methylphenyl)ethyl]amino]-2'-fluoro-3,5-dimethyl[1,1'-biphenyl]-4-yl]carbonyl]amino]-cyclopropanecarboxylic acid

CAS: 1233332-37-0

1-[[[5'-[[1-(4-Chloro-3-methylphenyl)ethyl]amino]-2'-fluoro-3,5-dimethyl[1,1'-biphenyl]-4-yl]carbonyl]amino]-cyclopropanecarboxylic acid (EMPA) is a cholesterol lowering drug that has been shown to decrease plasma …

• Fórmula: C₂₈H₂₈ClFN₂O₃
• Pureza: Min. 95%
• Peso molecular: 495 g/mol

Ex26

CAS: 1233332-37-0

Ex26 (S1P1-IN-Ex26) is an S1P1 antagonist used in experimental autoimmune encephalomyelitis, atherosclerosis, and gastric cancer.

• Fórmula: C₂₈H₂₈ClFN₂O₃
• Pureza: 99.62%
• Cor e Forma: Solid
• Peso molecular: 494.99